Global Allergy Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Allergy Therapeutics Market is presumed to reach the market size of nearly USD 40.54 BN by 2030 from USD 22.9 BN in 2022 with a CAGR of 7.4% under the study period 2023 - 2030.

Allergy therapeutics, also known as allergy immunotherapy or allergy shots, are medical treatments designed to help individuals with allergies build a tolerance to specific allergens (substances that trigger allergic reactions). Allergy is an immune system response to normally harmless substances like pollen, dust mites, pet dander, or certain foods. This can lead to sneezing, itching, congestion, hives, or even severe allergic reactions in some cases.

MARKET DYNAMICS:

The increasing prevalence of allergies worldwide, including conditions like allergic rhinitis, asthma, and food allergies, is positively affecting the market growth. Lifestyle changes, urbanization, and exposure to environmental allergens contribute to this trend, prompting individuals to seek effective allergy management solutions. Advancements in treatment modalities, including innovative options like sublingual immunotherapy (SLIT) tablets, offer patients more convenient and personalized alternatives to traditional allergy shots. Additionally, heightened patient awareness and education about allergies, coupled with improved healthcare infrastructure and access to specialized care, have led to greater demand for allergy therapeutics. Technological advancements in allergy testing, government initiatives promoting effective allergy management, and the recognition of occupational allergies further bolster the market. The rise in food allergies, global travel, and the need for insect venom allergy treatments also contribute to market growth. Ongoing research, clinical trials, and collaborations between pharmaceutical companies and academic institutions are driving the development of new and improved allergy therapeutics. As allergies continue to impact public health and well-being, the market is expected to expand, providing individuals with more effective and personalized options for allergy management.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of allergy therapeutics. The growth and trends of allergy therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the allergy therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment Type

Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs)
Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT))

By Type

Eye Allergy
Asthma
Skin Allergy
Food Allergies
Rhinitis
Other Allergy Types

By Route Of Administration

Oral
Inhalers
Intranasal
Other Routes Of Administration

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Allergy Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Allergy Therapeutics market include Allergopharma, Danaher, AbbVie Inc., Allergy Therapeutics plc, Sanofi SA, Pfizer Inc., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., and Merck & Co., Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112190

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ALLERGY THERAPEUTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment Type
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Route Of Administration
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

5.1 Overview by Treatment Type
5.2 Historical and Forecast Data
5.3 Analysis by Treatment Type
5.4 Anti-Allergy Drugs (Antihistamines, Corticosteroids., Other Drugs) Historic and Forecast Sales by Regions
5.5 Immunotherapy (Sub-Cutaneous Immunotherapy (SCIT), Sub-Lingual Immunotherapy (SLIT)) Historic and Forecast Sales by Regions

6 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY TYPE

6.1 Overview by Type
6.2 Historical and Forecast Data
6.3 Analysis by Type
6.4 Eye Allergy Historic and Forecast Sales by Regions
6.5 Asthma Historic and Forecast Sales by Regions
6.6 Skin Allergy Historic and Forecast Sales by Regions
6.7 Food Allergies Historic and Forecast Sales by Regions
6.8 Rhinitis Historic and Forecast Sales by Regions
6.9 Other Allergy Types Historic and Forecast Sales by Regions

7 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1 Overview by Route Of Administration
7.2 Historical and Forecast Data
7.3 Analysis by Route Of Administration
7.4 Oral Historic and Forecast Sales by Regions
7.5 Inhalers Historic and Forecast Sales by Regions
7.6 Intranasal Historic and Forecast Sales by Regions
7.7 Other Routes Of Administration Historic and Forecast Sales by Regions

8 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1 Overview by Distribution Channel
8.2 Historical and Forecast Data
8.3 Analysis by Distribution Channel
8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
8.5 Retail Pharmacies Historic and Forecast Sales by Regions
8.6 Other Distribution Channels Historic and Forecast Sales by Regions

9 . GLOBAL ALLERGY THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE ALLERGY THERAPEUTICS COMPANIES

10.1. Allergy Therapeutics Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF ALLERGY THERAPEUTICS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Allergopharma
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Danaher
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. AbbVie Inc.
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Allergy Therapeutics plc
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Sanofi SA
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Pfizer Inc.
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Teva Pharmaceutical Industries Ltd.
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. GlaxoSmithKline plc
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. F. Hoffmann-La Roche Ltd.
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Merck & Co. Inc.
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies